|
|
The
East of England IRC is working together with i10 to help facilitate access
to intellectual property and technologies developed by the East of
England's 10 Higher Education Institutions - Anglia Ruskin University,
Cranfield University, Norwich School of Art and Design, University
of Cambridge, University of East Anglia, University of Essex, University
of Hertfordshire, University of Bedfordshire, The Open University
and Writtle College.
'The
aim of i10 is to help businesses develop and exploit innovation
opportunities by providing access to the combined capabilities of
the region's universities.'
This
page provides details of i10 technologies and inetellectual property
currently offered through the East of England Innovation Relay Centre.
Click on name of the HEI below to reveal titles of offered technologies.
Click on the technology reference numbers to see details of the
offers.
Contact
us, quoting the reference, if you are interested in doing business
with the offering institution.
Disclaimer
Back
to top
Cambridge University
-
-
-
- Stimulation
of Neuronal Regeneration and Repair by Human a9ß1 Integrin
(Ref: 07 GB EAST 0HFY)
Researchers at a university in the East of England have shown
that human a9ß1 integrin mediates axon outgrowth and Schwann
cell migration, and offers excellent possibilities for neuronal
regeneration and repair within the central nervous system, including
spinal cord injury, brain injury, multiple sclerosis and neurodegenerative
diseases. The university is seeking commercial partners for licensing,
collaboration and development of this technology.
- A
fast, efficient and low-cost process for the production of high-purity
carbon-encapsulated magnetic nanoparticles (CEMNs) (Reference:
07 GB EAST 0HU8)
A UK university has developed a simple and relatively low-temperature
(~1000°C) one-step process for the production of high-purity
carbon-encapsulated magnetic nanoparticles (CEMNs). The scalable
process uses cheap, non-toxic, easy-to-handle raw materials, employs
simple equipment, and in contrast to existing production methods
produces yields of encapsulated particles close to 100%. The university
is looking for partners for further development and licensing.
- Novel
algorithms for object recognition and image matching (Reference:
06 GB EAST 0G8P)
Researchers at a university in the East of England have developed
a novel set of algorithms that allow fast comparison between images
of complex objects even when there are differences in viewpoint
and/or illumination. The technology can be applied in applications
such as robot navigation, aerial searching and trademark searching.
The university is looking for partners for further development
and licensing.
- Self-cleaning
surface coatings (Reference: 06 GB EAST 0GDI)
Researchers at a university in the East of England have developed
a coating technique that can be used to create self-cleaning surfaces.
The university is looking for partners for joint further development
and/or licensing of this technology.
- Novel
mouse model of advanced vulnerable Atherosclerosis (Reference:
06 GB EAST 0G3C)
Researchers
at a University in the East of England have engineered transgenic
mice that can develop a disease state that shares major features
of advanced vulnerable atherosclerosis in humans. This valuable
model is highly suited to studies of cardiovascular drugs and
the long term study of arterial diseases. The University is looking
for pharmaceutical and biotechnology companies to license the
technology.
-
Novel
method for the treatment of neurodegenerative disorders
(Reference:
06 GB EAST 0FGN)
Researchers at a university in the East of England have discovered
a method for influencing the levels of toxic proteins within
cells that are known to cause many neurodegenerative disorders
such as Huntington's disease and forms of Parkinson's disease.
The university is looking for collaboration and licensing relationships
with pharmaceutical or biotechnology companies for commercialisation
of this technology.
-
Novel
Method for Forming of Ductile Metal into Difficult Shapes (Reference:
06 GB EAST 0FW5)
A university in the East of England has developed a flexible,
high-performance route to forming shapes in ductile sheet materials.
The method employs simple and cheap tools and standard CNC machines,
offers high deformation and low residual stresses, and can be
applied to sheet, tube and other geometries. The technology
is available for trials, and the university is looking for commercial
companies for possible joint further development and/or licensing.
-
New
collagen peptides (Reference:
06 GB EAST 0FMO)
Researchers at a university in the East of England have developed
synthetic collagen peptides useful in modulating platelet aggregation
and activation. Potential applications include diagnostic reagents
to explore platelet function and thrombus formation, coating
wounds and implants to stimulate clotting. The university is
looking for commercial partners for licensing, collaboration
and development of these technologies.
-
Cognitive
testing device for rodents (Reference:
06 GB EAST 0FMQ)
Researchers at a university in the East of England have developed
a tool for cognitive screening of pharmacological, transgenic
and knockout rodent models that is high-throughput, non-aversive,
standardisable and easily implementable. The university is seeking
commercial partners for licensing, collaboration and development
of this technology.
-
Novel
protein for diagnostics and treatment of cancer, autoimmunity
and viral infection
(Reference:
05 GB EAST 0DNT)
Researchers at the University of Cambridge have identified and
characterised a novel member of the RAET1/ULBP family of proteins,
termed 'RAET1G', which has great potential for novel diagnostic
tests (e.g. tumour markers) and modulation of RAET1G activity
for treatment of diseases such as cancer, autoimmunity and viral
infection. The university is seeking to establish collaboration
and licensing relationships for commercialisation of this exciting
technology.
- New
Target for development of anti-cancer combination therapies
(Reference:
06 GB EAST 0FG0)
Researchers at a university in the East of England have discovered
a method to sensitise tumour cells to treatment with certain key
drugs used in chemotherapy that has great potential for the development
of combination therapies for the treatment of cancer. The university
is looking to establish collaboration and licensing relationships
with pharmaceutical or biotechnology companies for the commercialisation
of this technology.
- Novel
enzyme system for the formation of new DNA molecules (ligation)
(Reference:
06 GB EAST 0FGT)
Researchers at a university in the East of England have discovered
a novel enzyme system that catalyses the formation of new DNA
molecules from one or more fragments with much higher efficiency
than existing enzymes. It has a range of other activities and
has great potential to be a powerful new tool for molecular biologists.
The university is looking for collaboration and licensing relationships
with pharmaceutical or biotechnology companies for commercialisation
of this technology.
- New
target to block the reproduction of cancer cells (Reference:
06 GB EAST 0FGU)
Researchers at a university in the East of England have discovered
a method to reduce reproduction of cancer cells and make them
more sensitive to some of the key drugs used in chemotherapy.
The method has great potential for improving the responsiveness
of cancer cells to treatment with such drugs and the subsequent
development of combination therapies for treatment of cancer.
The university is looking for collaboration and licensing relationships
with pharmaceutical or biotechnology companies.
- New
target to enhance the effectiveness of anti-cancer drugs (Reference:
06 GB EAST 0FGM)
Researchers at a university in the East of England have identified
a novel molecular target to make cancer cells more sensitive to
some of the key drugs that are used in chemotherapy. The university
is looking for collaboration and licensing relationships with
pharmaceutical or biotechnology companies for commercialisation
of this technology.
- Technique
for the assessment and treatment of kidney disease (Reference:
05 GB EAST 0DLQ)
Researchers at the University of Cambridge have discovered that
a specific protein (Tumour Necrosis Factor) that plays a major
role in chronic inflammatory immune-mediated disorders can be
manipulated in a way that shows great potential for the assessment
and treatment of kidney diseases associated with inflammation
or ischemia (decrease in blood supply to an organ). The university
wishes to establish collaboration and licensing relationships
for the commercialisation of this exciting technology
-
Novel
technologies for the delivery of genes in gene therapy
(Reference:
05 GB EAST 0DLO)
Researchers
at the University of Cambridge have developed a series of effective
technologies for delivery of genes in gene therapy, based on
so-called lentiviral vectors. These have extensive intellectual
property protection including granted US patents. The university
is looking for collaboration and licensing relationships for
the commercialisation of this exciting technology.
-
Phyto-remediation
of metal-contaminated land: A low-cost in-situ organo-zeolitic-soil
system (Reference:
05 GB EAST 0CIF)
Researchers at universities in the UK and France, together with
a Canadian SME have developed an organo-zeolitic-soil technology
that promotes the sustained growth of plants on soils that are
heavily contaminated by metal wastes. The technology is low-cost,
functions in-situ and requires only a simple surface amendment
with this natural mineral-organic mixture. Partners are sought
to bring the technology to market through a licensing agreement,
joint venture or through technical collaboration.
Back
to top
Anglia Ruskin University
-
- Adaptive
control for power tools (Reference: 07 GB EAST 0H8A)
A university in the East of England has patented technology for power
tools that can adapt the tool operations to the object being cut or
in response to a number of environmental factors such as temperature,
material changes and the proximity water pipes or electrical cables.
The university is looking for manufacturers of power tools or machine
tools for joint further development and/or to license this technology.
- Novel
transmission - a globoid worm-gear drive (Reference: 07 GB EAST 0IBL)
A UK university group has developed 3D modelling called Virtual Reality
Machining. Design of previously too complex components is possible,
particularly in the field of transmission. A globoid worm-gear drive,
with several advantages, is the first product offered for joint development
and licensing. Partners will come from heavy machining e.g. elevators,
military and mining.
-
Highly
efficient, targeted transfection of cell subpopulations
(Reference: 07 GB EAST 0IBW)
A
UK university has developed a technology for the efficient transfection
of cells based upon their immunological identity. Antigen-coated
beads are used to shear transient holes in specific cells in
mixtures, allowing for chemical-free non-toxic highly efficient
transfection with minimal cell death. Regenerative medicine,
gene therapy, stem cell and chemotherapeutic companies, and
research labs are offered licenses and consultancy.
Disclaimer
The
information contained throughout this website is provided for convenience
as part of the services we offer. However, we cannot accept any liability
for its accuracy or content. Visitors who rely on this information
do so entirely at their own risk.
|
